miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2

Cancer Lett. 2013 May 10;332(1):94-101. doi: 10.1016/j.canlet.2013.01.023. Epub 2013 Jan 21.

Abstract

In this study, we detected miR-206 expression in gastric cancer (GC) and further investigated its effects on GC cell growth in vitro and in vivo. miR-206 expression was found to be significantly decreased in 30 GC samples and GC cell lines by real time-PCR. Restoration of miR-206 reduced cell growth and colony forming ability in GC cells with G0/G1 cell cycle arrest. Further studies demonstrated that miR-206 could suppress GC cells proliferation at least partially through targeting the cyclinD2 (CCND2). Therefore, we provided evidence that miR-206 was a potential tumor suppressor and may be used as a therapeutic target for gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Animals
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation*
  • Cyclin D2 / genetics
  • Cyclin D2 / metabolism*
  • Down-Regulation
  • Female
  • G1 Phase Cell Cycle Checkpoints
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs / metabolism*
  • Middle Aged
  • Oligonucleotides / metabolism
  • Promoter Regions, Genetic
  • Real-Time Polymerase Chain Reaction
  • Resting Phase, Cell Cycle
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology
  • Transfection
  • Tumor Burden

Substances

  • CCND2 protein, human
  • Cyclin D2
  • MIRN206 microRNA, human
  • MicroRNAs
  • Oligonucleotides